Appreciate differing views, but let’s keep the focus on...

Appreciate differing views, but let’s keep the focus on Zeotech’s current trajectory, not endlessly rehashing one individual’s past roles.

Many of us have been invested in ZEO well before James Marsh joined, and our interest remains rooted in the company’s core fundamentals, including its IP, market applications, and recent progress with Auspozz.

Healthy scrutiny is fair, but repetition becomes unproductive especially when it distracts from the actual milestones being achieved.

Let’s keep the discussion forward facing and relevant to what’s happening here and now with Zeotech.